News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
351,750 Results
Type
Article (21534)
Company Profile (142)
Press Release (330060)
Multimedia
Podcasts (112)
Webinars (17)
Section
Business (107431)
Career Advice (893)
Deals (19016)
Drug Delivery (110)
Drug Development (51666)
Employer Resources (80)
FDA (7950)
Job Trends (7894)
News (189573)
Policy (17721)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (784)
Accelerated approval (19)
Adcomms (23)
Allergies (83)
Alliances (28438)
ALS (92)
Alzheimer's disease (809)
Antibody-drug conjugate (ADC) (214)
Approvals (8141)
Artificial intelligence (285)
Autoimmune disease (79)
Automation (15)
Bankruptcy (180)
Best Places to Work (5597)
BIOSECURE Act (14)
Biosimilars (170)
Biotechnology (61)
Bladder cancer (76)
Brain cancer (34)
Breast cancer (265)
Cancer (2394)
Cardiovascular disease (241)
Career advice (742)
Career pathing (24)
CAR-T (113)
CDC (14)
Cell therapy (302)
Cervical cancer (14)
Clinical research (45368)
Collaboration (1030)
Company closure (1)
Compensation (371)
Complete response letters (52)
COVID-19 (1198)
CRISPR (50)
C-suite (538)
Cystic fibrosis (88)
Data (3381)
Decentralized trials (2)
Denatured (27)
Depression (83)
Diabetes (249)
Diagnostics (1988)
Digital health (15)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (174)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (139)
Earnings (41601)
Editorial (46)
Employer branding (10)
Employer resources (78)
Events (51782)
Executive appointments (620)
FDA (9555)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (662)
Gene editing (97)
Generative AI (31)
Gene therapy (271)
GLP-1 (825)
Government (2058)
Grass and pollen (4)
Guidances (207)
Healthcare (6100)
HIV (28)
Huntington's disease (24)
IgA nephropathy (62)
Immunology and inflammation (171)
Immuno-oncology (35)
Indications (70)
Infectious disease (1333)
Inflammatory bowel disease (118)
Inflation Reduction Act (12)
Influenza (46)
Intellectual property (139)
Interviews (118)
IPO (7603)
IRA (53)
Job creations (2455)
Job search strategy (655)
JPM (52)
Kidney cancer (10)
Labor market (61)
Layoffs (343)
Leadership (27)
Legal (4199)
Liver cancer (39)
Longevity (8)
Lung cancer (359)
Lymphoma (215)
Machine learning (21)
Management (31)
Manufacturing (524)
MASH (104)
Medical device (2180)
Medtech (2189)
Mergers & acquisitions (11949)
Metabolic disorders (883)
Multiple sclerosis (98)
NASH (20)
Neurodegenerative disease (164)
Neuropsychiatric disorders (71)
Neuroscience (1539)
Neurotech (1)
NextGen: Class of 2026 (2387)
Non-profit (960)
Now hiring (45)
Obesity (515)
Opinion (232)
Ovarian cancer (66)
Pain (148)
Pancreatic cancer (99)
Parkinson's disease (157)
Partnered (18)
Patents (286)
Patient recruitment (250)
Peanut (19)
People (34776)
Pharmaceutical (76)
Pharmacy benefit managers (33)
Phase 1 (14282)
Phase 2 (19110)
Phase 3 (15414)
Pipeline (2945)
Policy (235)
Postmarket research (1636)
Preclinical (4997)
Press Release (57)
Prostate cancer (132)
Psychedelics (27)
Radiopharmaceuticals (181)
Rare diseases (527)
Real estate (3259)
Recruiting (33)
Regulatory (13973)
Reports (25)
Research institute (879)
Resumes & cover letters (140)
Rett syndrome (6)
RNA editing (12)
RSV (45)
Schizophrenia (120)
Series A (123)
Series B (84)
Service/supplier (7)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (119)
Sponsored (20)
Startups (2066)
State (2)
Stomach cancer (12)
Supply chain (76)
Tariffs (94)
The Weekly (83)
Vaccines (411)
Venture capital (71)
Weight loss (376)
Women's health (40)
Worklife (9)
Date
Today (12)
Last 7 days (308)
Last 30 days (1217)
Last 365 days (15541)
2026 (1499)
2025 (15723)
2024 (17966)
2023 (20044)
2022 (26432)
2021 (27282)
2020 (25344)
2019 (20454)
2018 (15926)
2017 (17497)
2016 (16438)
2015 (19115)
2014 (14996)
2013 (12751)
2012 (13760)
2011 (14149)
2010 (12946)
Location
Africa (418)
Alabama (41)
Alaska (1)
Arizona (94)
Arkansas (8)
Asia (28760)
Australia (3422)
California (4849)
Canada (1831)
China (854)
Colorado (196)
Connecticut (196)
Delaware (180)
Europe (54070)
Florida (834)
Georgia (104)
Hawaii (2)
Idaho (18)
Illinois (445)
India (51)
Indiana (294)
Iowa (5)
Japan (326)
Kansas (83)
Kentucky (29)
Louisiana (7)
Maine (5)
Maryland (617)
Massachusetts (3908)
Michigan (68)
Minnesota (243)
Mississippi (3)
Missouri (42)
Montana (12)
Nebraska (14)
Nevada (39)
New Hampshire (10)
New Jersey (1913)
New Mexico (21)
New York (1325)
North Carolina (820)
North Dakota (2)
Northern California (2268)
Ohio (129)
Oklahoma (8)
Oregon (23)
Pennsylvania (1068)
Puerto Rico (19)
Rhode Island (27)
South America (620)
South Carolina (11)
Southern California (2055)
Tennessee (66)
Texas (658)
United States (18421)
Utah (95)
Virginia (179)
Washington D.C. (60)
Washington State (379)
West Virginia (1)
Wisconsin (49)
Wyoming (1)
351,750 Results for "xinogen hong kong pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
·
12 min read
Press Releases
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
December 30, 2025
·
3 min read
Press Releases
WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure
December 24, 2025
·
3 min read
Press Releases
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
December 2, 2025
·
5 min read
Press Releases
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
October 31, 2025
·
3 min read
Press Releases
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
October 17, 2025
·
15 min read
Press Releases
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
September 2, 2025
·
4 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
Deals
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
Sol-Gel Technologies, Ltd. announced that it has signed an asset purchase agreement with Chinese based Shenzhen Beimei Pharmaceutical Co. Ltd, for the commercialization of TWYNEO, for the treatment of acne vulgaris, in the mainland of China, Hong Kong, Macau, Taiwan and Israel.
May 16, 2024
·
7 min read
1 of 35,175
Next
